Longevitix

Company Overview

Snapshot

Founded in April 2025 by Effie Arditi, Neil Panchal, and Gaby Hayon, Longevitix operates with 1-10 employees. The company has raised $3.5M across one funding round from four investors.

Business overview

Longevitix is an AI-driven platform operating in the Health Tech & Life Sciences sector, specifically within Digital Healthcare, Clinical Workflow, and Digital Medical Diagnostics. The company provides solutions for physician practices to deliver preventive and longevity-focused care by automating patient enrollment, analyzing health data to identify risk factors, and generating personalized intervention plans. Its core technology integrates laboratory results and biomarkers for automated diagnostics, supporting clinical decision-making and ongoing patient management. Longevitix aims to streamline administrative and analytical processes for healthcare providers, enabling them to implement predictive and personalized care models.

Strategic signal

Longevitix was named a Catalyst Partner for The Longevity Show 2026 in March 2026. This partnership signals strong industry recognition and strategic alignment within the longevity and health tech ecosystem, positioning Longevitix for increased visibility and potential collaborations in a rapidly evolving market focused on preventive care and healthy aging.

Company Intelligence Q&A

When was Longevitix founded and by whom?

Longevitix was founded in April 2025 by Effie Arditi, Neil Panchal, and Gaby Hayon.

What was a key partnership for Longevitix in early 2026?

In March 2026, Longevitix was named a Catalyst Partner for The Longevity Show 2026.

Which investors participated in Longevitix's funding round in May 2026?

In May 2026, Longevitix received funding from SeedIL Ventures and Jibe Ventures.

What is Longevitix's total capital raised to date?

Longevitix has raised a total of $3.5M across one funding round.